Evidence map›Paper›PMID 39684303›Full record

ArticleInternational journal of molecular sciences2024

Features of Highly Homologous T-Cell Receptor Repertoire in the Immune Response to Mutations in Immunogenic Epitopes.

Ksenia Zornikova, Dmitry Dianov, Natalia Ivanova, Vassa Davydova, Tatiana Nenasheva, Ekaterina Fefelova, Apollinariya Bogolyubova

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ksenia ZornikovaNational Medical Research Center for Hematology, Moscow 125167, Russia.
Dmitry DianovNational Medical Research Center for Hematology, Moscow 125167, Russia.ORCID 0000-0002-2687-8482
Natalia IvanovaNational Medical Research Center for Hematology, Moscow 125167, Russia.ORCID 0000-0002-4725-6391
Vassa DavydovaNational Medical Research Center for Hematology, Moscow 125167, Russia.
Tatiana NenashevaNational Medical Research Center for Hematology, Moscow 125167, Russia.ORCID 0000-0002-1669-5244
Ekaterina FefelovaNational Medical Research Center for Hematology, Moscow 125167, Russia.ORCID 0000-0002-3296-503X
Apollinariya BogolyubovaNational Medical Research Center for Hematology, Moscow 125167, Russia.ORCID 0000-0002-8664-6341

Funding

Russian Science Foundation 20-15-00395
6 · The paper itself

Abstract

CD8+ T-cell immunity, mediated through interactions between human leukocyte antigen (HLA) and the T-cell receptor (TCR), plays a pivotal role in conferring immune memory and protection against viral infections. The emergence of SARS-CoV-2 variants presents a significant challenge to the existing population immunity. While numerous SARS-CoV-2 mutations have been associated with immune evasion from CD8+ T cells, the molecular effects of most mutations on epitope-specific TCR recognition remain largely unexplored, particularly for epitope-specific repertoires characterized by common TCRs. In this study, we investigated an HLA-A*24-restricted NYN epitope (Spike

Indexed as

CD8-Positive T-LymphocytesEpitopes, T-LymphocyteMutationReceptors, Antigen, T-CellSARS-CoV-2COVID-19HLA-A24 AntigenHumansJurkat CellsSpike Glycoprotein, CoronavirusEpitopes, T-LymphocyteHLA-A24 AntigenReceptors, Antigen, T-CellSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2COVID-19cross-reactivityimmune evasionpeptide–MHC interactionSARS-CoV-2T-cell epitopeT-cell receptorT-cell repertoire

Identifiers

PMID39684303
PMCPMC11641755

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.